19-41879281-G-A
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_001783.4(CD79A):c.371G>A(p.Arg124His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00184 in 1,612,416 control chromosomes in the GnomAD database, including 6 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R124C) has been classified as Uncertain significance.
Frequency
Consequence
NM_001783.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CD79A | NM_001783.4 | c.371G>A | p.Arg124His | missense_variant | 2/5 | ENST00000221972.8 | |
CD79A | NM_021601.4 | c.265+106G>A | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CD79A | ENST00000221972.8 | c.371G>A | p.Arg124His | missense_variant | 2/5 | 1 | NM_001783.4 | P1 | |
CD79A | ENST00000444740.2 | c.265+106G>A | intron_variant | 1 | |||||
CD79A | ENST00000597454.2 | c.371G>A | p.Arg124His | missense_variant | 2/4 | 3 |
Frequencies
GnomAD3 genomes AF: 0.000835 AC: 127AN: 152186Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.000761 AC: 187AN: 245628Hom.: 1 AF XY: 0.000788 AC XY: 105AN XY: 133254
GnomAD4 exome AF: 0.00195 AC: 2846AN: 1460112Hom.: 6 Cov.: 35 AF XY: 0.00189 AC XY: 1376AN XY: 726250
GnomAD4 genome AF: 0.000834 AC: 127AN: 152304Hom.: 0 Cov.: 31 AF XY: 0.000806 AC XY: 60AN XY: 74468
ClinVar
Submissions by phenotype
not provided Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Oct 05, 2022 | Reported in a patient with spondyloarthritis; however, no second variant was reported (Sogkas et al., 2020); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 33046446, 24728327) - |
Uncertain significance, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Agammaglobulinemia 3, autosomal recessive Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 25, 2023 | This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 124 of the CD79A protein (p.Arg124His). This variant is present in population databases (rs144367487, gnomAD 0.2%), including at least one homozygous and/or hemizygous individual. This missense change has been observed in individual(s) with rheumatic diseases and hypogammaglobulinaemia (PMID: 33046446). ClinVar contains an entry for this variant (Variation ID: 133834). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
not specified Other:1
not provided, no classification provided | reference population | ITMI | Sep 19, 2013 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at